Photo by nci from unsplash
1.2%. There was no apparent association between clopidogrel use and the incidence of postoperative bleeding (P 1⁄4 .59) or any other postoperative complication (stroke, death, MI, or cranial nerve injury;… Click to show full abstract
1.2%. There was no apparent association between clopidogrel use and the incidence of postoperative bleeding (P 1⁄4 .59) or any other postoperative complication (stroke, death, MI, or cranial nerve injury; P 1⁄4 .15). Conclusions: Clopidogrel use in our CEA practice has increased over time and has not been associated with an increased risk of postoperative complications, including bleeding. These data suggest that clopidogrel should not be discontinued before CEA and should be considered part of “optimal medical therapy” in patients having CEA.
Journal Title: Journal of Vascular Surgery
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!